Current Price | $4.90 | Mkt Cap | $514.8M |
---|---|---|---|
Open | $5.00 | P/E Ratio | -1.30 |
Prev. Close | $4.94 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $4.87 - $5.03 | Volume | 274,664 |
52-Wk Range | $4.57 - $37.98 | Avg. Daily Vol. | 1,813,983 |
Current Price | $4.90 | Mkt Cap | $514.8M |
---|---|---|---|
Open | $5.00 | P/E Ratio | -1.30 |
Prev. Close | $4.94 | Div. (Yield) | $0.00 (0.0%) |
Daily Range | $4.87 - $5.03 | Volume | 274,664 |
52-Wk Range | $4.57 - $37.98 | Avg. Daily Vol. | 1,813,983 |
The best Bull and Bear pitches based on recency and number of recommendations.
Read the most recent pitches from players about RVNC.
Recs
https://www.luf.org
Recs
I am a physician in Canada. I perform Botox injections as part of my practice. Every patient that I see seems to want Botox, but the fear of injection is the biggest barrier to them getting it, rather than price. That said, I have patients in their 20s to their 70s who do receive Botox injections. I have to say, that I am always nervous injecting a toxin into the skin that can potentially kill my patient, especially since this is an elective procedure. If I had a non-injectable form of Botox that I could simply apply on the skin rather than inject into it, I would stop offering my patients Botox brand injections immediately and start offering them the Revance product instead. I am certain that I would be able to recruit more patients with this product, compared to the injection.
Recs
Clinical trials look promising
Find the members with the highest scoring picks in RVNC.
skyrocket29 (68.55) Score: +121.09
The Score Leader is the player with the highest score across all their picks in RVNC.
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
---|---|---|---|---|---|---|---|---|---|---|
usubanas | 97.71 | 10/13/2023 | 5Y | $8.33 | -40.98% | +20.25% | -61.24 | 0 Comment | ||
FVelociraptor | 87.26 | 9/12/2023 | 5Y | $15.17 | -67.59% | +17.19% | -84.78 | 1 Comment | ||
tubogoo | < 20 | 5/31/2022 | 5Y | $13.66 | -64.00% | +26.76% | -90.76 | 0 Comment | ||
Emilie111 | 98.99 | 5/25/2023 | 5Y | $30.15 | -83.69% | +26.36% | -110.06 | 0 Comment | ||
RyanIdaho | 25.18 | 5/15/2023 | 5Y | $35.15 | -86.01% | +26.96% | -112.98 | 0 Comment | ||
TwinsEnt | 30.55 | 10/24/2022 | 5Y | $22.95 | -78.58% | +39.22% | -117.80 | 0 Comment | ||
usubanas2 | 89.04 | 10/10/2022 | 5Y | $28.60 | -82.81% | +45.08% | -127.89 | 0 Comment | ||
BioTech20 | 28.67 | 1/23/2020 | 5Y | $22.53 | -78.18% | +58.24% | -136.42 | 0 Comment | ||
Momentum21 | 32.32 | 1/3/2018 | 5Y | $36.78 | -86.63% | +94.10% | -180.73 | 0 Comment | ||
portefeuille3 | 91.47 | 12/27/2017 | 5Y | $36.70 | -86.60% | +95.68% | -182.29 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.